Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice

TGFβ signalling in context

Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,130 · see citing works

Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

Fearon, K. C. H., Glass, D. J., & D, D. C. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,203 · see citing works

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T. C., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 941 · see citing works

Understanding the mechanisms and treatment options in cancer cachexia

Fearon, K. C. H., Arends, J., & Baracos, V. E. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 937 · see citing works

Induction of Cachexia in Mice by Systemically Administered Myostatin

Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P. A., Esquela‐Kerscher, A., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S. (2002) · Science · doi:10.1126/science.1069525 · Cited by 908 · see citing works

Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges

Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893 · see citing works

α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice

Matzuk, M. M., Finegold, M. J., Su, J.-G. J., Hsueh, A. J. W., & Bradley, A. (1992) · Nature · doi:10.1038/360313a0 · Cited by 890 · see citing works

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792 · see citing works

Systemic delivery of genes to striated muscles using adeno-associated viral vectors

Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620 · see citing works

Cancer cachexia is regulated by selective targeting of skeletal muscle gene products

Acharyya, S., Ladner, K. J., Nelsen, L., Damrauer, J. S., Reiser, P. J., Swoap, S. J., & D, D. C. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20174 · Cited by 541 · see citing works

Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice

Shioi, T., McMullen, J., Tarnavski, O., Converso, K., Sherwood, M., Manning, W., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 482 · see citing works

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

Bernardo, B. C., Gao, X., Winbanks, C. E., Boey, E. J. H., Tham, Y. K., Kiriazis, H., Gregorevic, P., Obad, S., Kauppinen, S., Du, X., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206432109 · Cited by 431 · see citing works

Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014

von Haehling, S., & Anker, S. D. (2014) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-014-0164-8 · Cited by 394 · see citing works

Determinants of specificity in TGF-β signal transductionPreprint

Chen, Y., Hata, A., Lo, R. S., Wotton, D., Shi, Y., Pavletich, N. P., & Massagué, J. (1998) · Genes & Development · doi:10.1101/gad.12.14.2144 · Cited by 361 · see citing works

Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells

Liu, X., Sun, Y., Constantinescu, S. N., Karam, E., Weinberg, R. A., & Lodish, H. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10669 · Cited by 356 · see citing works

Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways

Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316 · see citing works

Myostatin/activin pathway antagonism: molecular basis and therapeutic potential

Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314 · see citing works

An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy

Lach-Trifilieff, E., Minetti, G. C., Sheppard, K., Ibebunjo, C., Feige, J. N., Hartmann, S., Brachat, S., Rivet, H., Koelbing, C., Morvan, F., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01307-13 · Cited by 306 · see citing works

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice

Gregorevic, P., Allen, J. M., Minami, E., Blankinship, M. J., Haraguchi, M., Meuse, L. A., Finn, E. E., Adams, M. E., Froehner, S. C., Murry, C. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1439 · Cited by 303 · see citing works

Regulation of Muscle Mass by Follistatin and Activins

Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0127 · Cited by 273 · see citing works

A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy

Mendell, J. R., Sahenk, Z., Malik, V., Gomez, A. M., Flanigan, K. M., Lowes, L. P., Alfano, L. N., Berry, K., Meadows, E., Lewis, S., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.200 · Cited by 246 · see citing works

Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure

Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.109.882068 · Cited by 238 · cited 1× · see citing works

Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer

Buchlis, G., Podsakoff, G. M., Radu, A., Hawk, S. M., Flake, A. W., Mingozzi, F., & High, K. A. (2012) · Blood · doi:10.1182/blood-2011-09-382317 · Cited by 221 · see citing works

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin

Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201109091 · Cited by 218 · see citing works

Role of Activin A and Myostatin in Human Cancer Cachexia

Loumaye, A., de Barsy, M., Nachit, M., Lause, P., Frateur, L., Maanen, A. G. V., Tréfois, P., Gruson, D., & Thissen, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4318 · Cited by 212 · see citing works

Role of interleukin-6 in cachexia

Narsale, A. A., & Carson, J. A. (2014) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000091 · Cited by 205 · see citing works

Elevated expression of activins promotes muscle wasting and cachexia

Chen, J. L., Walton, K. L., Winbanks, C. E., Murphy, K. T., Thomson, R. E., Makanji, Y., Qian, H., Lynch, G. S., Harrison, C. A., & Gregorevic, P. (2013) · The FASEB Journal · doi:10.1096/fj.13-245894 · Cited by 203 · see citing works

Elevated Levels of Activin A in Heart Failure

Yndestad, A., Ueland, T., Øie, E., Florholmen, G., Halvorsen, B. L., Attramadal, H., Simonsen, S., Frøland, S. S., Gullestad, L. L., Christensen, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000120704.97934.41 · Cited by 181 · see citing works

Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse

Aulino, P., Berardi, E., Cardillo, V., Rizzuto, E., Perniconi, B., Ramina, C., Padula, F., Spugnini, E. P., Baldi, A., Faiola, F., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-363 · Cited by 177 · see citing works

A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers

Attie, K. M., Borgstein, N. G., Yang, Y., Condon, C. H., Wilson, D. M., Pearsall, A. E., Kumar, R., Willins, D. A., Seehra, J. S., & Sherman, M. L. (2012) · Muscle & Nerve · doi:10.1002/mus.23539 · Cited by 176 · see citing works

Ectopic Expression of Myostatin Induces Atrophy of Adult Skeletal Muscle by Decreasing Muscle Gene Expression

Durieux, A., Amirouche, A., Banzet, S., Koulmann, N., Bonnefoy, R., Pasdeloup, M., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2007) · Endocrinology · doi:10.1210/en.2006-1500 · Cited by 162 · see citing works

Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice

Qiao, C., Li, J., Jiang, J., Zhu, X., Wang, B., Li, J., & Xiao, X. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.159 · Cited by 157 · see citing works

JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy

Raffaello, A., Milan, G., Masiero, E., Carnio, S., Lee, D., Lanfranchi, G., Goldberg, A. L., & Sandri, M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001136 · Cited by 156 · see citing works

Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival

Johnston, A. J., Murphy, K. T., Jenkinson, L., Laine, D., Emmrich, K., Faou, P., Weston, R. T., Jayatilleke, K. M., Schloegel, J., Talbo, G. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.031 · Cited by 152 · see citing works

Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders

Smith, R. C., & Lin, B. K. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000013 · Cited by 151 · see citing works

Activin signaling through activin receptor type II causes the cachexia- like symptoms in inhibin-deficient mice

Coerver, K. A., Woodruff, T. K., Finegold, M. J., Mather, J. P., Bradley, A., & Matzuk, M. M. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.5.8732684 · Cited by 149 · see citing works

Measles and rubella elimination in the WHO Region for Europe: progress and challenges

O’Connor, P. M., Jankovic, D., Muscat, M., Mamou, M. C. B., Reef, S. E., Papania, M. J., Singh, S., Kaloumenos, T., Butler, R., & Datta, S. S. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.003 · Cited by 123 · see citing works

Mouse Model for Hereditary Hemorrhagic Telangiectasia Has a Generalized Vascular Abnormality

Torsney, E., Charlton, R., Diamond, A. G., Burn, J., Soames, J. V., & Arthur, H. M. (2003) · Circulation · doi:10.1161/01.cir.0000058170.92267.00 · Cited by 120 · see citing works

Myostatin Gene Inactivation Prevents Skeletal Muscle Wasting in Cancer

Gallot, Y. S., Durieux, A., Castells, J., Desgeorges, M. M., Vernus, B., Plantureux, L., Rémond, D., Jahnke, V. E., Lefai, É., Dardevet, D. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0057 · Cited by 117 · see citing works

Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease

Ju, C., & Chen, R. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.07.016 · Cited by 114 · see citing works

Antibody-Directed Myostatin Inhibition Enhances Muscle Mass and Function in Tumor-Bearing Mice

Murphy, K. T., Chee, A., Gleeson, B. G., Naim, T., Swiderski, K., Koopman, R., & Lynch, G. S. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00121.2011 · Cited by 111 · see citing works

A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling

Koncarevic, A., Kajimura, S., Cornwall-Brady, M. R., Andreucci, A., Pullen, A. E., Sako, D., Kumar, R., Grinberg, A. V., Liharska, K., Ucran, J. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1016 · Cited by 109 · see citing works

Serum immunoreactive activin A levels in normal subjects and patients with various diseases

Harada, K., Shintani, Y., Sakamoto, Y., WAKATSUKI, M., Shitsukawa, K., & Saito, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964839 · Cited by 101 · see citing works

Overexpression of activin A in stage IV colorectal cancer

Wildi, S., Kleeff, J. H., Maruyama, H., Maurer, C. A., Büchler, M. W., & Korc, M. (2001) · Gut · doi:10.1136/gut.49.3.409 · Cited by 101 · see citing works

Myostatin represses physiological hypertrophy of the heart and excitation–contraction coupling

Rodgers, B. D., Interlichia, J. P., Garikipati, D. K., Mamidi, R., Chandra, M., Nelson, O. L., Murry, C. E., & Santana, L. F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172544 · Cited by 73 · see citing works

The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism

Jackson, M. F., Luong, D., Vang, D. D., Garikipati, D. K., Stanton, J. B., Nelson, O. L., & Rodgers, B. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0455 · Cited by 64 · see citing works

No longer going to waste

Garber, K. (2016) · Nature Biotechnology · doi:10.1038/nbt.3557 · Cited by 56 · see citing works

Treating cancer cachexia to treat cancer

Lee, S., & Glass, D. J. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-2 · Cited by 49 · see citing works

Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration

Cohen, T. V., Kollias, H. D., Liu, N., Ward, C. W., & Wagner, K. R. (2015) · The Journal of Physiology · doi:10.1113/jp270201 · Cited by 45 · see citing works

Myostatin Is Upregulated Following Stress in an Erk-Dependent Manner and Negatively Regulates Cardiomyocyte Growth in Culture and in a Mouse Model

Bish, L. T., Morine, K., Sleeper, M. M., & Sweeney, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010230 · Cited by 42 · see citing works

Myostatin Regulates Tissue Potency and Cardiac Calcium-Handling Proteins

Jackson, M. F., Li, N., & Rodgers, B. D. (2014) · Endocrinology · doi:10.1210/en.2013-2014 · Cited by 17 · see citing works

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease

Sartori, R., Romanello, V., & Sandri, M. (2021) · Nature Communications · doi:10.1038/s41467-020-20123-1 · Cited by 940 · see citing works

The Parabrachial Nucleus: CGRP Neurons Function as a General Alarm

Palmiter, R. D. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.007 · Cited by 442 · see citing works

Signaling Pathways That Control Muscle Mass

Vainshtein, A., & Sandri, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134759 · Cited by 214 · see citing works

Activin A in Mammalian Physiology

Bloise, E., Ciarmela, P., Cruz, C. D., Luisi, S. V., Petraglia, F., & dos Reis, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00002.2018 · Cited by 200 · see citing works

Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia

Sartori, R., Hagg, A., Zampieri, S., Armani, A., Winbanks, C. E., Viana, L. R., Haidar, M., Watt, K. I., Qian, H., Pezzini, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9592 · Cited by 158 · see citing works

Muscle-specific and age-related changes in protein synthesis and protein degradation in response to hindlimb unloading in rats

Baehr, L. M., West, D. W. D., Marshall, A. G., Marcotte, G. R., Baar, K., & Bodine, S. C. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00703.2016 · Cited by 119 · see citing works

Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease

Chen, J. L., Walton, K. L., Hagg, A., Colgan, T. D., Johnson, K., Qian, H., Gregorevic, P., & Harrison, C. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620013114 · Cited by 116 · see citing works

Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies

Martin, A., Gallot, Y. S., & Freyssenet, D. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13073 · Cited by 103 · see citing works

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs

Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111 · see citing works

LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01429-1 · Cited by 112 · see citing works

New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials

Shi, H., Huang, Z., Xu, T., Sun, A., & Ge, J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103968 · Cited by 107 · see citing works

Mechanistic Role of Reactive Oxygen Species and Therapeutic Potential of Antioxidants in Denervation- or Fasting-Induced Skeletal Muscle Atrophy

Qiu, J., Fang, Q., Xu, T., Wu, C., Xu, L., Wang, L., Yang, X., Yu, S., Zhang, Q., Ding, F., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00215 · Cited by 103 · see citing works

Unlockable Nanocomplexes with Self‐Accelerating Nucleic Acid Release for Effective Staged Gene Therapy of Cardiovascular Diseases

Nie, J., Qiao, B., Duan, S., Chen, X., Chen, B., Hao, W., Yu, B., Li, Y., Du, J., & Xu, F. (2018) · Advanced Materials · doi:10.1002/adma.201801570 · Cited by 101 · see citing works

Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies

Martin, A., & Freyssenet, D. G. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12678 · Cited by 97 · see citing works

Isoquercitrin Delays Denervated Soleus Muscle Atrophy by Inhibiting Oxidative Stress and Inflammation

Shen, Y., Zhang, Q., Huang, Z., Zhu, J., Qiu, J., Ma, W., Yang, X., Ding, F., & Sun, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00988 · Cited by 95 · see citing works

A Key Role for the Ubiquitin Ligase UBR4 in Myofiber Hypertrophy in Drosophila and Mice

Hunt, L. C., Stover, J., Haugen, B., Shaw, T. I., Li, Y., Pagala, V. R., Finkelstein, D., Barton, E. R., Fan, Y., Labelle, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.094 · Cited by 90 · see citing works

Muscle Atrophy: Present and Future

Cao, R. Y., Li, J., Dai, Q., Li, Q. X., & Yang, J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_29 · Cited by 75 · see citing works

MYTHO is a novel regulator of skeletal muscle autophagy and integrity

Leduc‐Gaudet, J., Franco‐Romero, A., Cefis, M., Moamer, A., Broering, F. E., Milan, G., Sartori, R., Chaffer, T. J., Dulac, M., Marcangeli, V., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36817-1 · Cited by 73 · see citing works

Celecoxib Alleviates Denervation-Induced Muscle Atrophy by Suppressing Inflammation and Oxidative Stress and Improving Microcirculation

Zhang, L., Li, M., Wang, W., Yu, W., Liu, H., Wang, K., Chang, M., Deng, C., Ji, Y., Shen, Y., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115186 · Cited by 66 · see citing works

Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review)

Yang, W., Huang, J., Wu, H., Wang, Y., Du, Z., Ling, Y., Wang, W., Wu, Q., & Gao, W. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11608 · Cited by 64 · see citing works

Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Schcolnik‐Cabrera, A., Chávez-Blanco, A. D., Domínguez-Gómez, G., & Dueñas‐González, A. (2017) · Europe PMC (PubMed Central) · Cited by 54 · see citing works

Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions

Li, J., Yang, T., Tang, H., Sha, Z., Chen, R., Chen, L., Yu, Y., Rowe, G. C., Das, S., & Xiao, J. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.002 · Cited by 52 · see citing works

Activin A: an emerging target for improving cancer treatment?

Ries, A., Schelch, K., Falch, D., Pany, L., Hoda, M. A., & Grusch, M. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1799350 · Cited by 45 · see citing works

Past, Present, and Future Perspective of Targeting Myostatin and Related Signaling Pathways to Counteract Muscle Atrophy

Hoogaars, W. M. H., & Jaspers, R. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_8 · Cited by 42 · see citing works

Regulation of solute carriers oct2 and OAT1/3 in the kidney: a phylogenetic, ontogenetic, and cell dynamic perspective

Casellas, C. P., Jansen, K., Rookmaaker, M. B., Clevers, H. C., Verhaar, M. C., & Masereeuw, R. (2021) · Physiological Reviews · doi:10.1152/physrev.00009.2021 · Cited by 40 · see citing works

The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy

Graça, F. A., Rai, M., Hunt, L. C., Stephan, A., Wang, Y., Gordon, B., Wang, R., Quarato, G., Xu, B., Fan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30120-1 · Cited by 41 · see citing works

Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation

Yi, X., Tao, J., Yu, Q., Feng, F., Hu, X., Xu, T., Jin, H., Ruan, H., Zheng, H., & Tong, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1056460 · Cited by 37 · see citing works

Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species

Xu, T., Yang, X., Wu, C., Qiu, J., Fang, Q., Wang, L., Yu, S. Y., & Sun, H. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.112 · Cited by 37 · see citing works

Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis

Miao, C.-X., Lv, Y.-Y., Zhang, W., Chai, X., Feng, L.-X., Fang, Y., Liu, X., & Zhang, X.-W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00915 · Cited by 35 · see citing works

The Mechanical Stimulation of Myotubes Counteracts the Effects of Tumor-Derived Factors Through the Modulation of the Activin/Follistatin Ratio

Baccam, A., Sviercovich, A., Rocchi, M., Moresi, V., Seelaender, M. C. L., Li, Z., Adamo, S., Xue, Z., & Coletti, D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00401 · Cited by 34 · see citing works

Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut‐renal muscle axis

Pei, T., Zhu, D., Yang, S., Hu, R., Wang, F., Zhang, J., Yan, S., Ju, L., He, Z., Han, Z., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17626 · Cited by 35 · see citing works

Master Regulators of Muscle Atrophy: Role of Costamere Components

Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M. (2021) · Cells · doi:10.3390/cells10010061 · Cited by 31 · see citing works

AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions

Guo, M., Zhang, J., Ma, Y., Zhu, Z., Zuo, H., Yao, J., Wu, X., Wang, D., Yu, J., Meng, M., et al. (2023) · Aging Cell · doi:10.1111/acel.13961 · Cited by 29 · see citing works

Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy

Roy, A., & Kumar, A. (2022) · Nature Communications · doi:10.1038/s41467-022-29752-0 · Cited by 28 · see citing works

Leptin induces muscle wasting in kras-driven hepatocellular carcinoma (HCC) model in zebrafish

Yang, Q., Yan, C., Wang, X., & Gong, Z. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038240 · Cited by 26 · see citing works

Screening for gene doping transgenes in horses via the use of massively parallel sequencing

Maniego, J., Pesko, B., Habershon‐Butcher, J., Huggett, J. F., Taylor, P., Scarth, J. A., & Ryder, E. (2021) · Gene Therapy · doi:10.1038/s41434-021-00279-1 · Cited by 25 · see citing works

Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives

Charrier, D., Cerullo, G., Carpenito, R., Vindigni, V., Bassetto, F., Simoni, L., Moro, T., & Paoli, A. (2024) · Antioxidants · doi:10.3390/antiox13091027 · Cited by 22 · see citing works

Genome-wide epigenetic dynamics during postnatal skeletal muscle growth in Hu sheep

Cao, Y., Ai, Y., Zhang, X., Zhang, J., Long, X., Zhu, Y.-N., Wang, L., Gu, Q., & Han, H. (2023) · Communications Biology · doi:10.1038/s42003-023-05439-0 · Cited by 21 · see citing works

Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia

Vudatha, V., Devarakonda, T., Liu, C., Freudenberger, D. C., Riner, A. N., Herremans, K. M., & Trevino, J. (2022) · Cells · doi:10.3390/cells11061040 · Cited by 21 · see citing works

Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice

Rodgers, B. D., Bishaw, Y. M., Kagel, D. R., Ramos, J. N., & Maricelli, J. W. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.015 · Cited by 20 · see citing works

Myostatin promotes tenogenic differentiation of C2C12 myoblast cells through Smad3

Uemura, K., Hayashi, M., Itsubo, T., Oishi, A., Iwakawa, H., Komatsu, M., Uchiyama, S., & Kato, H. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12200 · Cited by 19 · see citing works

Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes

Rao, V. K., Das, D., & Taneja, R. (2022) · Cancers · doi:10.3390/cancers14174258 · Cited by 19 · see citing works

The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signaling

Jaime, D., Fish, L. A., Madigan, L. A., Xi, C., Piccoli, G., Ewing, M. D., Blaauw, B., & Fallon, J. R. (2024) · Skeletal Muscle · doi:10.1186/s13395-023-00329-9 · Cited by 18 · see citing works

Signaling networks governing skeletal muscle growth, atrophy, and cachexia

Joshi, A. S., da Silva, M. T., Kumar, S., & Kumar, A. (2025) · Skeletal Muscle · doi:10.1186/s13395-025-00397-z · Cited by 20 · see citing works

Tumour‐induced alterations in single‐nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolism

Agca, S., Domaniku, A., Bilgiç, Ş. N., Sucuoglu, M., Dag, M., Doğan, Ş. A., & Kır, S. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13540 · Cited by 17 · see citing works

State- and stimulus-specific dynamics of SMAD signaling determine fate decisions in individual cells

Bohn, S., Hexemer, L., Huang, Z., Strohmaier, L., Lenhardt, S., Legewie, S., & Loewer, A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210891120 · Cited by 15 · see citing works

Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions

Directo, D., & Lee, S.-R. (2023) · Metabolites · doi:10.3390/metabo13091024 · Cited by 12 · see citing works

Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes

Davey, J. R., Estévez, E., Thomson, R. E., Whitham, M., Watt, K. I., Hagg, A., Qian, H., Henstridge, D. C., Ludlow, H., Hedger, M. P., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201802059rrr · Cited by 15 · see citing works

A “self-accelerating endosomal escape” siRNA delivery nanosystem for significantly suppressing hyperplasia via blocking the ERK2 pathway

Gao, B., Zhang, Q., Wang, X., Wang, M., Ren, X., Guo, J., Xia, S., Zhang, W., & Feng, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm00451c · Cited by 14 · see citing works

Systemic SMAD7 Gene Therapy Increases Striated Muscle Mass and Enhances Exercise Capacity in a Dose-Dependent Manner

Maricelli, J. W., Bishaw, Y. M., Wang, B., Du, ‬., & Rodgers, B. D. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.158 · Cited by 13 · see citing works

TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass

Hagg, A., Kharoud, S., Goodchild, G., Goodman, C. A., Chen, J. L., Thomson, R. E., Qian, H., Gregorevic, P., Harrison, C. A., & Walton, K. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.560225 · Cited by 13 · see citing works

The Small Molecule ACM-001 Improves Cardiac Function in a Rat Model of Severe Cancer Cachexia

Poetsch, M. S., Palus, S., Linthout, S. V., von Haehling, S., Doehner, W., Coats, A. J. S., Anker, S. D., & Springer, J. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2840 · Cited by 13 · see citing works

MiR-378 and BMP-Smad can influence the proliferation of sheep myoblast

Lu, Z., Du, L., Liu, R., Di, R., Zhang, L., Ma, Y., Li, Q., Liu, E., Chu, M., & Wei, C. (2018) · Gene · doi:10.1016/j.gene.2018.06.039 · Cited by 13 · see citing works

Sulforaphane Enhanced Proliferation of Porcine Satellite Cells via Epigenetic Augmentation of SMAD7

Zhang, R., Neuhoff, C., Yang, Q., Çınar, M. U., Uddin, M. J., Tholen, E., Schellander, K., & Tesfaye, D. (2022) · Animals · doi:10.3390/ani12111365 · Cited by 12 · see citing works

FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy

Mina, E., Wyart, E., Sartori, R., Angelino, E., Zaggia, I., Rausch, V., Maldotti, M., Pagani, A., Hsu, M. Y., Friziero, A., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101306 · Cited by 12 · see citing works

SMAD7: riding on fibrosis-limiting routes and beyond

Martin, L., Gabbiani, G., & Meyer, G. R. Y. D. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00283-7 · Cited by 10 · see citing works

Development and validation of a model gene therapy biodistribution assay for AVGN7 using digital droplet polymerase chain reaction

Rodgers, B. D., Herring, S. K., Carias, D. R., Chen, J., & Rocha, A. G. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.05.007 · Cited by 10 · see citing works

The Molecular Mechanisms and Prevention Principles of Muscle Atrophy in Aging

Zhang, Y., Pan, X., Sun, Y., Geng, Y., Yu, X., & Li, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_16 · Cited by 11 · see citing works

MicroRNAs and their Modulatory Effect on the Hallmarks of Osteosarcopenia

Silva, W. J., Cruz, A., & Duque, G. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00880-4 · Cited by 9 · see citing works

Therapy-naïve malignancy causes cardiovascular disease: a state-of-the-art cardio-oncology perspective

Ogilvie, L. M., Coyle‐Asbil, B., Brunt, K. R., Petrik, J., & Simpson, J. A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2023 · Cited by 9 · see citing works

A Combination of Resveratrol and Quercetin Prevents Sarcopenic Obesity: Its Role as a Signaling Inhibitor of Myostatin/ActRIIA and ActRIIB/Smad and as an Enhancer of Insulin Actions

Cano-Martı́nez, A., Méndez-Castro, J. A., García-Vázquez, V. E., Carreón‐Torres, E., Díaz‐Díaz, E., Sánchez-Aguilar, M., Castrejón-Téllez, V., & Rubio-Ruiz, M. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104952 · Cited by 9 · see citing works

Emerging role of TAK1 in the regulation of skeletal muscle mass

Roy, A., Narkar, V. A., & Kumar, A. (2023) · BioEssays · doi:10.1002/bies.202300003 · Cited by 8 · see citing works

RNA signaling in skeletal muscle: the central role of microRNAs and exosomal microRNAs

Liu, S., & Dong, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1639123 · Cited by 8 · see citing works

Electroporation of Small Interfering RNAs into Tibialis Anterior Muscles of Mice

Stephan, A., Graça, F. A., Hunt, L. C., & Demontis, F. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4428 · Cited by 6 · see citing works

Myostatin-driven muscle hypertrophy: a double-edged sword in muscle physiology

Dewasi, G., Nagda, P., Bahl, G., Jain, V., & Gupta, S. K. (2025) · Journal of Rare Diseases · doi:10.1007/s44162-025-00086-x · Cited by 7 · see citing works

Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i

Maricelli, J. W., Kagel, D. R., Bishaw, Y. M., Nelson, O. L., Lin, D. C., & Rodgers, B. D. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00287.2017 · Cited by 6 · see citing works

Overcoming nature’s paradox in skeletal muscle to optimise animal production

Lynch, G. S., & Koopman, R. (2019) · Animal Production Science · doi:10.1071/an19361 · Cited by 6 · see citing works

Fiber-type vulnerability and proteostasis reprogramming in skeletal muscle during pancreatic cancer cachexia

Xu, B., Joshi, A. S., da Silva, M. T., Liu, S., & Kumar, A. (2026) · JCI Insight · doi:10.1172/jci.insight.200396 · Cited by 5 · see citing works

GDF10 exacerbates metastatic burden and cachexia in murine models of cancer

James, L. S., Saunders, A. A. E., Karagiannis, C., Qian, H., Anderson, R. L., Thomson, R. E., Goodman, C. A., & Gregorevic, P. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1773275 · Cited by 3 · see citing works

An ionic liquid-based delivery system of small interfering RNA targeting Bcl-2 for melanoma therapy

Xing, Y., Hu, Y., Wang, H., Diao, Y., & Yue, H. (2024) · Biomaterials Science · doi:10.1039/d4bm01159g · Cited by 3 · see citing works

Preclinical and clinical studies on cancer-associated cachexia

Widner, D. B., Files, D. C., Weaver, K. E., & Shiozawa, Y. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1484-4 · Cited by 3 · see citing works

Muscle Disuse Atrophy

Yeo, D. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_8 · Cited by 4 · see citing works

Gene Therapy and Gene Editing for Cancer Therapeutics

Mandal, S., & Tiwari, P. K. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-6530-8.ch004 · Cited by 2 · see citing works

Advancing cancer cachexia diagnosis with -omics technology and exercise as molecular medicine

Hesketh, S. J. (2024) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2024.01.006 · Cited by 2 · see citing works

Gene Therapy and Gene Editing for Cancer Therapeutics

Mandal, S., & Tiwari, P. K. (2023) · IGI Global eBooks · doi:10.4018/979-8-3693-3026-5.ch033 · Cited by 2 · see citing works

Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy

Rodgers, B. D., & Ward, C. W. (2025) · Gene Therapy · doi:10.1038/s41434-025-00583-0 · Cited by 1 · see citing works

TGFβ pathway represses hepatic ribosome biogenesis and protein synthesis by regulating p70S6K–S6RP proteins

Stavropoulos, A., Stamatopoulou, V., Pavlos, E., Manioudaki, M., Sakellariou, S., Stathopoulos, C., & Xilouri, M. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00853-0 · Cited by 1 · see citing works

Improving Sports Performance? Enhancements and the Future of Sport

Trothen, T. J. (2018) · SpringerBriefs in religious studies · doi:10.1007/978-3-030-02997-5_2 · Cited by 1 · see citing works

Promising preclinical approaches to combating cancer-associated cachexia/tissue wasting

Epstein, S. A., Dasgupta, A., & Doles, J. D. (2025) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000763 · Cited by 1 · see citing works

Hyperactivation of Transforming Growth Factor-β–Activated Kinase 1 Causes Skeletal Muscle Pathology Reminiscent of Inflammatory Myopathies

da Silva, M. T., Roy, A., & Kumar, A. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.07.005 · Cited by 1 · see citing works

Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseases

Herring, S. K., & Rodgers, B. D. (2025) · Gene Therapy · doi:10.1038/s41434-025-00578-x · Cited by 1 · see citing works

KLF10: a point of convergence in cancer cachexia

Epstein, S. A., Doles, J. D., & Dasgupta, A. (2024) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000711

Validation of a Göttingen Minipig Gene Therapy Biodistribution Assay for AVGN7 Using Droplet Digital Polymerase Chain Reaction

Rocha, A. G., Yu, T., Loveland, M., Patel, D. H., & Rodgers, B. D. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01145-3

Additional file 4 of LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578028

Additional file 6 of LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578034

Additional file 2 of The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signaling

Jaime, D., Fish, L. A., Madigan, L. A., Xi, C., Piccoli, G., Ewing, M. D., Blaauw, B., & Fallon, J. R. (2024) · Figshare · doi:10.6084/m9.figshare.26659651

Additional file 5 of LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578031

Additional file 2 of LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578022

Additional file 1 of LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578019

Additional file 1 of The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signaling

Jaime, D., Fish, L. A., Madigan, L. A., Xi, C., Piccoli, G., Ewing, M. D., Blaauw, B., & Fallon, J. R. (2024) · Figshare · doi:10.6084/m9.figshare.26659648

Additional file 3 of LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia

Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578025

Dualités fonctionnelles de GASP-1 et GASP-2, deux protéines multi-domaines antagonistes de la myostatine

Parenté, A. (2019) · doi:10.70675/3d9a23f5z3546z46f1z957cz5d167994539d

Développement de nouvelles approches thérapeutiques pour la dystrophie musculaire de Duchenne, basées sur l'utilisation de vésicules extracellulaires

Vaubourg, C. (2020) · theses.fr (ABES) · doi:10.70675/6e311fbez5d96z45fbza67az0975b1147486

Role of the glucocorticoid pathway in skeletal muscle wasting and hepatic metabolism rewiring during cancer cachexia in ApcMin/+ mice – Functional implication of myostatin gene invalidation

Martin, A. (2020) · doi:10.70675/07b25380z415fz4a5cza9daz7e26b69912d9

Identification of new levers to fight muscle atrophy : benefit of the hibernating brown bear model

Cussonneau, L. (2022) · doi:10.70675/1a11a81bzf829z4ba2zba9az6f3f4841c773

Sex-divergent skeletal muscle remodeling emerges early in cancer cachexia

Karagiannis, C., Saunders, A. A. E., Thomson, R. E., Guillán‐Fresco, M., Du, W. X., Goodman, C. A., & Gregorevic, P. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00271.2026

Elevated expression of activins promotes muscle wasting and cachexia

Chen, J. L., Walton, K. L., Winbanks, C. E., Murphy, K. T., Thomson, R. E., Makanji, Y., Qian, H., Lynch, G. S., Harrison, C. A., & Gregorevic, P. (2013) · The FASEB Journal · doi:10.1096/fj.13-245894 · Cited by 203 · see citing works

Targeting activins to counteract muscle wasting and cachexia

Chen, J. B. (2017) · Figshare · doi:10.4225/03/58b3a7a71a436

Role of Activin A in human cancer cachexia

Loumaye, A. (2021) · Digital Access to Libraries

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T. C., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 941 · see citing works